Skip to main content

Table 3 Univarate Cox regression analyses for clinical, histological, and PET/MRI parameters at baseline

From: Prognostic value of combined MTV and ADC derived from baseline FDG PET/MRI in aggressive non-Hodgkins lymphoma

Prognostic factor

Hazards ratio (95% CI)

P value

ECOG PS ≥2

13.3 (2.4–75.2)

.01

HGBCL

7.6 (1.4–43.0)

.02

Age

1.0 (0.9–1.1)

.42

Gender

1.0 (0.2–5.6)

.97

Number of extranodal sites ≥2

1.8 (0.4–8.9)

.47

Ann Arbor stage III/IV

0.8 (0.2–4.8)

.87

Bulk

0.8 (0.7–3.9)

.77

IPI high ≥4–5

1.6 (0.3–9.0)

.56

LDH elevated

1.2 (0.2–6.7)

.81

B-symptoms

1.9 (0.4–9.6)

.42

ADCmean

2.3 (1.1–5.5)

.02

ADCmin

1.8 (0.8–4.2)

.19

MTV

1.4 (0.7–2.7)

.34

MTV/ADCmean

1.8 (0.2–14.4)

.58

MTV/ADCmin

1.0 (0.2–4.6)

.96

  1. ECOG PS Eastern Cooperative Oncology Group Performance Status, HGBCL High-grade B-cell lymphoma, IPI International Prognostic Index, LDH Lactate Dehydrogenase, ADC Apparent diffusion coefficient, MTV Metabolic tumor volume